<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN" "JATS-archivearticle1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="case-report" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JPSIM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Pakistan Society of Internal Medicine</journal-title>
        <abbrev-title>J Pak Soc Intern Med</abbrev-title>
      </journal-title-group>
      <issn publication-format="print">2709-8729</issn>
      <issn publication-format="electronic">2710-0804</issn>
      <publisher>
        <publisher-name>Pakistan Society of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.70302/jpsim.v7i2.2634</article-id>
      <article-id pub-id-type="publisher-id">jpsim.v7i2.2634</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Multicentric Castleman Disease of Hyaline Vascular Type Presenting as Cervical Lymphadenopathy with Systemic Inflammatory Features in a Young Male</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Fatima</surname>
            <given-names>Najum</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mumtaz</surname>
            <given-names>Arslan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <institution>Saleem Memorial Hospital, Lahore, Pakistan</institution>
      </aff>
      <author-notes>
        <corresp id="cor1">*Correspondence: Najum Fatima</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2026-06-03">
        <day>03</day>
        <month>06</month>
        <year>2026</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2026</year>
      </pub-date>
      <volume>7</volume>
      <issue>2</issue>
      <fpage>165</fpage>
      <lpage>168</lpage>
      <history>
        <date date-type="received" iso-8601-date="2025-10-09">
          <day>09</day>
          <month>10</month>
          <year>2025</year>
        </date>
        <date date-type="rev-recd" iso-8601-date="2026-04-15">
          <day>15</day>
          <month>04</month>
          <year>2026</year>
        </date>
        <date date-type="accepted" iso-8601-date="2026-05-03">
          <day>03</day>
          <month>05</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2026 The Author(s)</copyright-statement>
        <copyright-year>2026</copyright-year>
        <copyright-holder>The Author(s)</copyright-holder>
        <ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v7i2.2634" content-type="text/html"/>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v7i2.2634.pdf" content-type="application/pdf"/>
      <abstract>
        <p>Castleman disease is a rare lymphoproliferative disorder with unicentric and multicentric forms. It can mimic tuberculosis, lymphoma, systemic lupus erythematosus and other inflammatory diseases, making diagnosis challenging. Excess interleukin-6 activity is central to many systemic manifestations, particularly in idiopathic multicentric Castleman disease. A 20-year-old male presented with a slowly enlarging left cervical swelling for two years, with rapid progression over three months, evening low-grade fever, night sweats, anorexia and 8-10 kg weight loss. Examination revealed a hard, non-tender left cervical mass. CRP and IL-6 were elevated, while autoimmune, HIV, HHV-8, viral and tuberculosis workup was negative. CT showed a left anterior cervical chain mass with hilar and inguinal lymph node involvement. Excision biopsy demonstrated hyaline vascular Castleman disease morphology. The clinicoradiological and histopathological findings supported multicentric Castleman disease, hyaline vascular type. Because siltuximab was not locally available, the patient was treated with tocilizumab 8 mg/kg intravenously every two weeks, along with tapering corticosteroids. After six doses, he achieved complete remission. This case highlights that Castleman disease should be considered in chronic cervical lymphadenopathy with constitutional symptoms after excluding infection, autoimmune disease and malignancy. Early excision biopsy, systemic staging and targeted anti-IL-6 therapy can lead to excellent clinical response in HHV-8-negative multicentric disease.</p>
      </abstract>
      <kwd-group xml:lang="en" kwd-group-type="author-keywords">
        <title>Keywords</title>
        <kwd>Castleman disease</kwd>
        <kwd>multicentric Castleman disease</kwd>
        <kwd>hyaline vascular type</kwd>
        <kwd>cervical lymphadenopathy</kwd>
        <kwd>interleukin-6</kwd>
        <kwd>tocilizumab</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <!-- <body> omitted: no manuscript (.docx) on file -->
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation>Sikora M, Dąbrowska-Leonik N, Buda P, Wolska-Kuśnierz B, Jahnz-Różyk K, Pac M, et al. Castleman Disease—Still More Questions than Answers: A Case Report and Review of the Literature. J Clin Med. 2025;14(8):2799.</mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation>Iyer S, Bhatti MI, Halliday M. Castleman’s disease—A case report. Int J Surg Case Rep. 2010;1(3):25–26.</mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation>Wang L, Chen H, Shi J, Tang H, Li H, Zheng W, et al. Castleman disease mimicking systemic lupus erythematosus: A case report. Medicine (Baltimore). 2018;97(38):e12291.</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation>Hu W, Kong Y, Hu B, Ai J, Zhang P. Atypical clinical presentation associated with Castleman disease: a case report and review of the literature. Front Med. 2025; 12:e1626722.</mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation>Izuchukwu IS, Tourbaf K, Mahoney MC. An unusual presentation of Castleman’s disease: a case report. BMC Infect Dis. 2003; 3:20.</mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation>Saadallah MAH. Castleman’s disease: A rare case report and review of literature. Int J Surg Case Rep. 2022; 95:107282.</mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation>Eward WC, DeWitt SB, Brigman BE, Kontogeorgakos V, Lagoo AS. Extranodal Castleman disease of the extremities: a case report and review of the literature. Skeletal Radiol. 2014; 43(6):1627–31.</mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation>Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017; 129(12):1646–57.</mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation>Van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018; 132(20):2115–24.</mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation>Lang E, van Rhee F. Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advances. Blood Rev. 2024; 64:e101161.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
